EnRich Financial Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-42
Closed -$32.7K 148
2024
Q4
$32.7K Hold
42
0.01% 120
2024
Q3
$37.5K Sell
42
-13
-24% -$11.7K 0.01% 118
2024
Q2
$50K Buy
55
+13
+31% +$10.4K 0.02% 105
2024
Q1
$32.8K Buy
+42
New +$29.9K 0.01% 109

Other funds holding LLY

EnRich Financial Partners's LLY Position: Q1 2025 in Review

EnRich Financial Partners sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 42 shares — an estimated $32.7K sold.

EnRich Financial Partners first reported a position in LLY in Q1 2024 and held it in 4 quarters. The position peaked at $50K in Q2 2024. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • EnRich Financial Partners reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • EnRich Financial Partners sold 42 Eli Lilly shares in Q1 2025, an estimated $32.7K.
  • EnRich Financial Partners first reported a position in Eli Lilly in Q1 2024 and held it in 4 quarters.
  • EnRich Financial Partners's Eli Lilly position peaked at $50K in Q2 2024.
  • 3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on EnRich Financial Partners's 13F filing for Q1 2025, filed 25 Apr 2025.